Vanguard Mid-Cap ETF

In 4Q14, TPG-Axon Capital Management increased holdings in Huntsman (HUN), Allison Transmission Holdings (ALSN), KAR Auction Services (KAR), and Zynga (ZNGA).

LKQ (LKQ) fell 4.6% to close at $30.93 per share during the third week of December 2016.

In its 2Q17 earnings conference call, Edwards Lifesciences (EW) projected 2017 adjusted EPS to fall to $3.65–$3.85, which is higher than the previous $3.43–$3.55.

In early 2017, Jazz Pharmaceuticals (JAZZ) expanded its sales force team from 35 to 55 and expanded its field reimbursement teams to support the commercial launch of Vyxeos in the US.

This trial demonstrated the efficacy and safety of JAZZ’s JZP-110 in both the MWT and sleep latency tests at all dosages at the end of weeks 4 and 12.

Erwinaze saw net sales worth $49 million in 2Q17, almost flat compared to the drug’s revenues of $50 million in 2Q16.

In 2Q17, Dentsply Sirona’s (XRAY) Dental and Healthcare Consumables business contributed ~56% to the company’s total revenues and registered sales of ~$554 million.

International market strategy In 2Q17, Align Technology (ALGN) reported 85,400 Invisalign case shipments in international markets, which is YoY (year-over-year) growth of ~37.4% and sequential growth of ~13.6%. This growth was mainly attributed to new customers in the EMEA (Europe, the Middle East, and Africa) and Asia-Pacific markets. If Align Technology continues to demonstrate solid […]

To diversify its focus beyond aortic structural heart conditions, Edwards Lifesciences (EW) acquired CardiAQ Valve Technologies in August 2015.

In 2Q17, Edwards Lifesciences’ (EW) Transcatheter Heart Valve Therapy segment reported revenues close to $316 million, which represents year-over-year growth of ~28%.

In 1Q17, around 12.1 million members were enrolled in Centene’s (CNC) various healthcare plans, which is a year-over-year (or YoY) rise of around 600,000 beneficiaries.

With around 50.0% of hospitals being served by Quest Diagnostics (DGX), the company has become a leading player in the fragmented US laboratory market.

Ball Corporation declared a cash dividend of $0.13 per share on its common stock. It will be paid on March 15 to shareholders of record as of March 1, 2017.

Harley-Davidson (HOG) reported 3Q16 Motorcycle and Related Products revenues of $1.09 billion, a fall of 4.4% from the $1.14 billion reported in 3Q15.

Ball Corporation (BLL) reported 3Q16 net sales of $2.8 billion, a rise of 33.3% compared to net sales of $2.1 billion in 3Q15.

Harley-Davidson (HOG) has a market cap of $10.4 billion. It fell 1.2% to close at $58.29 per share on November 15, 2016.

Ball Corporation (BLL) fell 0.80% to close at $76.48 per share during the first week of November 2016.

Ball Corporation (BLL) has a market cap of $13.9 billion. It fell 0.28% to close at $79.53 per share on October 26, 2016.

Price movement Harley-Davidson (HOG) rose 13.1% to close at $56.37 per share during the third week of October 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were 13.1%, 8.5%, and 27.2%, respectively, as of October 21. HOG is trading 9.2% above its 20-day moving average, 8.1% above its 50-day moving average, and […]

LKQ Corporation (LKQ) reported 2Q16 revenue of $2.5 billion, a rise of 38.9% compared to revenue of $1.8 billion in 2Q15.

Harley-Davidson (HOG) has a market cap of $9.4 billion. It rose 0.21% to close at $52.59 per share on September 30, 2016.

Ball Corporation (BLL) has a market cap of $13.8 billion. It fell 0.38% to close at $79.04 per share on September 26.

Harley-Davidson (HOG) rose 1.6% to close at $52.52 per share during the third week of September 2016.

Harley-Davidson rose by 0.36% to close at $52.89 per share on September 1, 2016. Its weekly, monthly, and YTD price movements were -0.66%, 2.4%, and 18.5%.